04/07/2026
The FDA has removed the age restriction for neffy 1 mg, expanding access to a needle-free epinephrine option for children at risk of severe allergic reactions.
Eligibility is now based on weight alone, meaning patients who weigh at least 33 lbs (15 kg) can use neffy 1 mg regardless of age. This change is especially important for younger children who previously met the weight requirement but were excluded due to age limits.
For FARE, this matters because increasing epinephrine options help overcome real-world treatment barriers. More choices allow families to select what works best for them and empower families to act confidently when treating anaphylaxis.
